BlackRock Takes Majority Stake in Nearly 150 CenterWell Senior Primary Care Clinics
Humana is handing BlackRock a majority stake in nearly 150 CenterWell Senior Primary Care clinics in a $2.8 billion joint venture that replaces an existing ownership arrangement and gives the insurer more room to maneuver. The transaction keeps CenterWell in a minority ownership position while leaving day-to-day clinic management unchanged, preserving the company’s current operating model even as the capital structure shifts beneath it.
The deal is expected to close by the end of the year.
For Humana, the move is about balance-sheet pressure as much as growth. The company said the transaction will reduce liabilities and unlock additional capital for expansion, a notable change for a payer that has spent recent years building a larger care-delivery footprint to diversify beyond insurance margins. Senior-focused primary care has become a central pillar of that strategy because it allows tighter control over utilization, disease management, and total cost of care for Medicare beneficiaries.
A Cleaner Capital Structure for a Growing Primary Care Platform
The transaction replaces a prior arrangement with Welsh, Carson, Anderson & Stowe, which had backed roughly 150 clinics through the earlier joint venture. BlackRock will buy out that existing ownership stake, and Humana is positioning the new structure as more flexible and less constraining than the old one. A key change is the removal of the put option that had been embedded in the former deal. In practical terms, that clause could force Humana to repurchase equity at a preset price even if the timing was not ideal for the company’s finances.
Removing that obligation matters because it lowers a contingent liability and reduces the chance that future capital would need to be diverted unexpectedly to settle an ownership buyback. In its place, CenterWell will gain the option to buy clinics from the joint venture starting in 2028. If all clinics have not been acquired by the end of 2033, BlackRock can exit by selling the remaining assets, with CenterWell retaining the right to make the first offer. The structure gives Humana a longer runway and less near-term financial friction while still preserving a path to eventually consolidate ownership if it chooses.
Humana said the arrangement should produce a significantly lower cost of capital, reflecting the maturity of the business. That language signals that CenterWell has moved far enough beyond its startup phase to attract a different kind of financing relationship—one built less on expansion-stage risk and more on scale, steady operations, and asset value.
CenterWell Remains Central to Humana’s Primary Care Strategy
Humana has been expanding its primary care delivery business for years, and CenterWell now operates more than 350 senior primary care locations through CenterWell Senior Primary Care and its sister brand, Conviva Senior Primary Care. The company has used acquisitions and new investments to broaden its clinical footprint, with the goal of increasing access for older adults who often carry multiple chronic conditions, complex medication regimens, and high hospitalization risk.
That model is built around value-based primary care, where the physician group’s revenue and operating performance are tied to keeping patients healthier and avoiding avoidable downstream costs. In Medicare populations, that can mean more intensive chronic disease monitoring, earlier intervention for decompensation, and tighter coordination across specialty and post-acute settings. Humana’s bet is that owning and operating more of the care funnel will improve both medical outcomes and economic performance over time.
The BlackRock transaction gives that strategy more capital support. Over the next two years, the investment firm will help fuel CenterWell’s growth, including clinic construction and additional acquisitions, according to Humana. For a business focused on senior care, new locations are not simply real estate plays; they are the physical infrastructure needed to place clinicians closer to high-need patients and to scale panels in markets where Medicare Advantage penetration and chronic disease burden are already high.
Humana’s CenterWell and Conviva platforms already form one of the largest senior-focused primary care networks in the country. The company described the earlier partnerships with WCAS as instrumental in scaling CenterWell into the nation’s largest provider of senior-focused value-based primary care over the past seven years.
Financial Pressure, Investor Scrutiny, and the Next Earnings Call
The timing of the deal also reflects the broader pressure on Humana’s finances. The insurer has been working through a turnaround after losses in 2024 and 2025 tied to unexpectedly high medical spending. Against that backdrop, a transaction that lowers liabilities and releases capital serves a clear strategic purpose: it gives management more flexibility while the payer side of the business remains under strain.
Humana said the deal is not expected to change its 2026 earnings forecast. Investors will likely use the company’s third-quarter earnings report on Nov. 6 to press for more detail on how the joint venture works in practice, how much operational freedom CenterWell will really have, and what protections BlackRock received in exchange for the majority stake. J.P. Morgan analyst Lisa Gill flagged those issues as areas likely to draw attention, especially given the fine print around acquisition rights and exit mechanics.
The commercial logic here is straightforward. Humana wants capital efficiency; BlackRock wants exposure to a scaled primary care platform with recurring patient demand; and CenterWell wants room to keep growing without the burden of a structure that can force an expensive buyback. The clinical side does not change immediately, but the ownership math around it does.
What the Deal Means for Senior Primary Care Expansion
The clinics themselves are not changing hands in a way that should alter patient care at the bedside, but the transaction could influence how quickly the platform expands and how aggressively it pursues new markets. A better-funded ownership structure can speed up clinic buildouts, support acquisitions, and deepen operational investment in staffing, care coordination, and population health tools. In senior primary care, those capabilities often determine whether a clinic can absorb a medically complex panel and still keep access tight enough to prevent gaps in care.
At the same time, the deal introduces a longer-term ownership arc that extends to 2033. That gives Humana and BlackRock a longer period to extract value from the platform before the right to exit becomes relevant. For now, the most immediate effect is financial rather than clinical: fewer liabilities, more capital, and a cleaner path for CenterWell to keep expanding its footprint in Medicare-focused primary care.
The unanswered issue is how much the new structure will change the pace of acquisitions and the economics of growth once the initial transaction closes. Investors will get their next check on that when Humana reports earnings in November, but the real test will come over the next several years as CenterWell decides whether to buy back clinics, build new ones, or keep leaning on outside capital to scale.